Dr Hutson gives an overview of the current treatment options available for metastatic renal cell carcinoma (mRCC) and stresses the importance of choosing an appropriate first-line treatment.

GlaxoSmithKline fully provided for the costs of this symposium, honoraria for the chairs & speakers and provided input into the symposium agenda/content.